iRadimed Corporation Announces Q3 2025 Financial Results Call
iRadimed Corporation (NASDAQ: IRMD) is set to unveil its third-quarter financial results for 2025 on November 3, 2025, prior to the market opening. The company's management will conduct a conference call that same day at 11:00 a.m. Eastern Time to delve into these results and engage with participants through a Q&A session.
Participating in the Conference Call
For those wanting to join the conference call, registration can be completed easily online. Once registered, participants will receive a unique dial-in number and PIN along with further instructions via email. This seamless process encourages stakeholders to connect and gain insights directly from the management team.
Listening to the Conference Call Online
Additionally, the conference call will stream live on the internet, allowing stakeholders to follow along from anywhere. After the call concludes, a recorded version will be accessible on iRadimed's official website, ensuring that anyone can catch up on what was discussed, regardless of their availability during the live event.
About iRadimed Corporation
iRadimed Corporation stands at the forefront of developing innovative magnetic resonance imaging (MRI) compatible medical devices. They are uniquely recognized as the sole provider of a non-magnetic intravenous (IV) infusion pump system that is specifically crafted to be safely used during MRI procedures. This groundbreaking technology addresses many conventional risks of using standard infusion pumps, which often include magnetic and electronic components that can interfere with the MRI process.
Innovative Medical Solutions for Critical Care
The company’s patented MRidium® MRI compatible IV infusion pump system features a non-magnetic ultrasonic motor and non-ferrous parts. This design enables safe and reliable delivery of anesthesia and other IV fluids during MRI procedures. The technology is particularly vital for critically ill patients who cannot be interrupted from their essential medications, as well as for children who may require sedation to remain still during scans.
Advancements in MRI Patient Monitoring
iRadimed has also introduced the 3880 MRI compatible patient vital signs monitoring system, tailored with non-magnetic components to ensure accurate and dependable monitoring during MRI procedures. This device operates effectively in magnetic fields up to 30,000 gauss, which is crucial for success in any MRI scanner room. Its compact design allows for easy transportation with patients, offering uninterrupted vital signs monitoring.
Key Features of the 3880 Monitoring System
The Iradimed 3880 offers a range of advanced features, such as wireless ECG capabilities, wireless SpO2 monitoring, and non-magnetic respiratory CO2 assessments. It not only facilitates blood pressure monitoring (both invasive and non-invasive) but also allows for temperature checks and advanced multi-gas anesthetic measurements. Beyond technical specifications, this system fosters effective communication between clinicians and patients by providing real-time vital signs data.
Contact Information
For any inquiries or further information regarding iRadimed Corporation’s products or the upcoming conference call, stakeholders and interested parties can reach out directly via contact channels provided on their website. Customer support is a priority, and the team is committed to ensuring accurate information accessibility.
Frequently Asked Questions
1. When will iRadimed release its Q3 financial results?
The financial results will be released on November 3, 2025, before the market opens.
2. How can I participate in the conference call?
Registration for the conference call can be completed online, after which you will receive a unique dial-in number and additional instructions.
3. Will the conference call be available after it takes place?
Yes, a recording of the call will be accessible on the company’s website following the live event.
4. What products does iRadimed specialize in?
iRadimed specializes in MRI compatible medical devices, including IV infusion pumps and patient monitoring systems designed for use during MRI procedures.
5. Who can I contact for more information?
Contacts can reach out to the investor relations team or customer support through the company's official website or provided contact details.
